Current Edition

The Relevance of the Guidelines on Good Distribution Practice (GDP) in the World of International Clinical Trials

The successful execution of international clinical trials requires the involvement of service providers adhering to a wide range of regulatory guidelines and industry standards including the Good Clinical Practice (GCP), the Good Manufacturing Practice (GMP) or the Good Laboratory Practice (GLP). Companies following the guidelines of Good Distribution Practice (GDP) are also involved in ensuring that the logistics and quality assurance requirements of the products used in clinical trials are duly met. Tibor KOVÁCS at PHARMAROAD KFT. aspires to highlight the different aspects of Good Distribution Practice (GDP) that are relevant to the sector of clinical trial management.